REBECCA PFABE: Open Payments
NPI 1356357586 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$383 in 7 payments from 5 companies in 2025. Trend: 2023 $417 · 2024 $263 · 2025 $383
Food & beverage: $383
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $146 |
| ABBVIE INC. | 2 | $94 |
| Corcept Therapeutics | 1 | $74 |
| Novartis Pharmaceuticals Corporation | 1 | $35 |
| Novo Nordisk Inc | 1 | $34 |
Products named: REXULTI, Korlym, UBRELVY, Wegovy, QULIPTA.
Industry payments across NE — which companies pay providers there.
